Moderna receives $176 million to accelerate development of pandemic bird flu vaccine as concerns grow

Moderna to receive $176 million to develop pandemic flu vaccine using mRNA technology like COVID-19 vaccine, aiding in future pandemic responses and public health crisis management.

Bird flu outbreak in dairy cows prompts funding for late-stage mRNA vaccine development, as CDC reports infections in 12 states and three cases in humans, with low general public risk.

Read at www.mercurynews.com